Core Viewpoint - The company Longshen Rongfa announced a cash dividend distribution plan for the first half of 2025, proposing a distribution of 0.2 yuan per 10 shares, totaling approximately 6.07 million yuan, which represents 21.70% of its net profit [1][4]. Company Distribution History - The company has a history of cash distributions since its listing, with the latest plan being the eighth distribution. The cash distribution amounts and dividend yields for previous distributions are as follows: - 2025.06.30: 0.06 billion yuan, 0.21% yield - 2024.12.31: 0.06 billion yuan, 0.22% yield - 2024.06.30: 0.06 billion yuan, 0.23% yield - 2023.12.31: 0.06 billion yuan, 0.20% yield - 2019.12.31: 0.03 billion yuan, 0.15% yield - 2018.12.31: 0.03 billion yuan, 0.11% yield - 2017.12.31: 0.04 billion yuan, 0.05% yield - 2016.12.31: 0.09 billion yuan, 0.14% yield [2]. Financial Performance - For the first half of 2025, the company reported total revenue of 496 million yuan, a year-on-year decrease of 8.21%. However, net profit reached 27.96 million yuan, reflecting a year-on-year increase of 27.48%. The basic earnings per share were 0.0922 yuan, with a weighted average return on equity of 4.08% [2]. Market Position - In terms of cash distribution within the pharmaceutical and biotechnology sector, Longshen Rongfa's cash distribution of 6.07 million yuan ranks lower compared to its peers. For instance, WuXi AppTec led the sector with a distribution of 1.003 billion yuan, followed by Dong-E E-Jiao and China Resources Sanjiu with distributions of 817.21 million yuan and 751.31 million yuan, respectively [3].
陇神戎发2025半年度分配预案:拟10派0.2元